{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0030154",
      "entity_text" : "differentiation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01270",
      "entity_text" : "PTH",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the present study, intermittent PTH 1-34 administration enhanced the osteogenic differentiation potential of MSCs impaired in osteoporosis, concurrent with previous reports regarding the effects of PTH on bone marrow derived MSCs (BM-MSCs).",
  "reading_complete" : "2020-08-04T17:59:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T17:57:23Z",
  "trigger" : "enhanced",
  "evidence" : [ "PTH 1-34 administration enhanced the osteogenic differentiation" ],
  "pmc_id" : "6330838",
  "score" : 0
}